Sherry Coonse McCraw
About Sherry Coonse McCraw
Independent Class III director at OneMedNet (ONMD), age 57, serving since October 2024 with a term expiring at the 2026 Annual Meeting. She brings 30 years of leadership at BMW Manufacturing Co., LLC across engineering, finance (including CFO/Vice President Finance), manufacturing operations (Vice President of Assembly Manufacturing), and Human Resources (current Vice President HR). She holds a B.S. in Textile Engineering from North Carolina State University and is designated by ONMD’s Board as an Audit Committee financial expert. Independence status: independent under Nasdaq and SEC rules. Attendance: no director attended fewer than 75% of Board and committee meetings in FY2024. Executive sessions: independent directors meet in executive session at each regularly scheduled Board meeting.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| BMW Manufacturing Co., LLC | Testing and Finish operations (start of career) | 1993 onward (multiple roles) | Foundation in assembly, planning, engineering, technology steering |
| BMW Manufacturing Co., LLC | Project Manager, Munich (structural planning for 2nd-gen BMW X5) | 2001 | Major platform planning responsibility |
| BMW Manufacturing Co., LLC | Planning Manager, Assembly & Technology Steering | 2004 | Assembly planning leadership |
| BMW Manufacturing Co., LLC | Managed 1.2M sq ft plant expansion for X3 | 2007 | Large-scale capacity expansion |
| BMW Manufacturing Co., LLC | Led $900M plant expansion (5th expansion) | 2011 | Largest single BMW investment; significant capex execution |
| BMW Manufacturing Co., LLC | Chief Financial Officer and Vice President Finance | 2013 | Senior financial leadership (CFO) |
| BMW Manufacturing Co., LLC | Vice President of Assembly Manufacturing | March 2018 – April 2022 | Led both production halls |
| BMW Manufacturing Co., LLC | Vice President of Human Resources | April 2022 – present | Current executive role |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| North Carolina Textile Foundation | Director | Current | Governance oversight for academic foundation |
Board Governance
- Committee assignments: Audit Committee member; Audit Committee held 4 meetings in 2024. Audit Committee Chair: Dr. Kenneth Alleyne. McCraw qualifies as an “audit committee financial expert” under SEC rules.
- Other committees: Not listed as a member of Compensation or Nominating & Corporate Governance.
- Independence: Board determined McCraw is independent under Nasdaq and SEC rules.
- Attendance: No director attended fewer than 75% of Board and committee meetings in FY2024; Board held 2 meetings in 2024; Compensation Committee (1), Nominating & Corporate Governance (2), Audit (4).
- Executive sessions: Independent directors meet in executive session during each regularly scheduled Board meeting.
- Risk oversight: Audit Committee oversees financial reporting and cybersecurity; Compensation oversees compensation risk; Nominating & Governance manages independence/conflicts.
Fixed Compensation
| Component | FY2024 Amount | Notes |
|---|---|---|
| Annual retainer (cash) | $0 | No cash retainer; policy reimburses reasonable out-of-pocket expenses |
| Committee membership fees | $0 | No committee fees disclosed |
| Committee chair fees | $0 | Not a chair; no chair fees disclosed |
| Meeting fees | $0 | No per-meeting fees disclosed |
| Equity – RSUs (policy) | 45,000 RSUs per full year | Automatic annual grant under Director Compensation Policy adopted April 2024 |
| FY2024 Equity – RSU grant fair value | $6,579 | Her FY2024 stock award grant-date fair value; likely prorated due to October appointment |
Performance Compensation
| Metric Type | Disclosed for Directors? | Notes |
|---|---|---|
| Performance-based equity (PSUs) | None disclosed | Director compensation is time-based RSUs under policy; no disclosed performance metrics |
| Cash bonus tied to metrics | None disclosed | No director cash bonuses disclosed |
No director performance metrics (e.g., revenue growth, EBITDA, TSR) are disclosed for director compensation at ONMD; director equity is time-based RSUs under the policy.
Other Directorships & Interlocks
| Company/Organization | Public Company? | Role | Potential Interlock/Conflict |
|---|---|---|---|
| North Carolina Textile Foundation | No (foundation) | Director | No ONMD-related transactions disclosed |
No public company directorships or interlocks with ONMD competitors/suppliers/customers were disclosed for McCraw.
Expertise & Qualifications
- Deep cross-functional expertise: engineering, large-scale manufacturing expansions ($900M), finance (CFO), and human resources leadership at BMW.
- Audit Committee financial expert designation by ONMD Board (SEC-defined).
- Education: B.S. in Textile Engineering, North Carolina State University.
Equity Ownership
| Holder | Shares Beneficially Owned | Ownership % | Notes |
|---|---|---|---|
| Sherry Coonse McCraw | 11,342 | <1% | As of Oct 23, 2025; no breakdown of vested vs unvested disclosed |
| Hedging/Pledging Policy | Prohibits hedging, short sales, and cashless collars; insider trading restrictions apply. | — | Strengthens alignment; no pledging activity disclosed for McCraw |
Insider Trades
| Item | Date/Period | Detail |
|---|---|---|
| Section 16(a) filings – timeliness | FY2024 | Form 3 and Form 4 filings for McCraw (initial equity award upon Board appointment on Oct 1, 2024) were not filed on a timely basis, per ONMD disclosure. |
Governance Assessment
-
Strengths
- Independent director with designation as Audit Committee financial expert; sits on Audit Committee, which met 4 times in 2024.
- Strong operational and financial leadership credentials from a global manufacturer (BMW), including major capex execution and CFO experience; relevant for audit oversight and internal controls.
- Board-level policies: clawback adopted Nov 2024; prohibitions on hedging/short sales/options; independent directors meet in executive session.
- Director pay structure is equity-heavy with no cash fees or meeting fees, aligning director incentives with long-term shareholder value.
-
Watch items / RED FLAGS
- Late Section 16 filings (Form 3/4) noted for McCraw in FY2024; while administrative, repeated delays can signal governance process weaknesses.
- Modest personal stake: 11,342 shares (<1%); alignment exists via annual RSUs but ownership is limited in absolute terms.
- No disclosed public company boards or interlocks—reduces conflict risk, but also limits market-facing governance experience in public issuer contexts.
-
Conflicts and related-party exposure
- No related-party transactions involving McCraw disclosed; Audit Committee reviews related-party transactions under policy.
-
Attendance and engagement
- Board held 2 meetings in 2024; no director attended fewer than 75% of Board and committee meetings—no attendance red flags disclosed.
-
Committee structure and effectiveness
- Audit chaired by Dr. Alleyne; McCraw is a member and designated financial expert—positive for financial oversight. Compensation and Nominating committees fully independent; clear charters and responsibilities.
Overall, McCraw enhances ONMD’s audit oversight through financial expert designation and extensive finance/operations background, with alignment supported by equity-based director pay and hedging prohibitions. Process discipline should be reinforced around timely Section 16 reporting to avoid governance optics issues.